A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Dabuzalgron | Dabuzalgron (Ro 115-1240) is an orally active and selective α-1A adrenergic receptor agonist for the treatment of urinary incontinence. Dabuzalgron protects against Doxorubicin-induced cardiotoxicity by preserving mitochondrial function[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Ro 115-1240. CAS No. 219311-44-1. Pack Sizes: 5 mg; 10 mg. Product ID: HY-117071. |  |
| dA(Bz)-3'-PS Phosphoramidite | dA(Bz)-3'-PS Phosphoramidite is a deoxyadenosine-derived phosphoramidite designed for oligonucleotide synthesis with a 3'-phosphorothioate (PS) linkage. In this modification, a non-bridging oxygen atom in the phosphate backbone is replaced by a sulfur atom, significantly improving nuclease resistance and biological stability of the oligonucleotides. The adenine base is protected with a benzoyl (Bz) group at the N6 position to prevent side reactions during synthesis while maintaining proper base-pairing properties. This phosphoramidite is particularly valuable in therapeutic oligonucleotide development, such as antisense oligonucleotides and siRNA, where enhanced stability, enzymatic resistance, and prolonged biological activity are critical for efficacy. Alternative Names: 5'-DMT-dA(Bz)-3'-PS-Phosphoramidite; dA(Bz) ThioPhosphamidite; Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-, 3'-[S-[2-(benzoylthio)ethyl] P-1-pyrrolidinylphosphonothioite]; Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-, 3'-[S-[2-(benzoylthio)ethyl] 1-pyrrolidinylphosphonothioite]; S-(2-(((((2R,3S,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl)oxy)(pyrrolidin-1-yl)phosphaneyl)thio)ethyl) benzothioate. Grades: ≥90%. CAS No. 178272-29-2. Molecular formula: C51H51N6O7PS2. Mole weight: 955.09. |  |
| dA(Bz)-PACE Phosphoramidite | dA-PACE Phosphoramidite is a crucial reagent utilized in the development of oligonucleotide therapeutics for treating various genetic disorders such as cystic fibrosis and Huntington's disease. The unique PACE (phosphoramidite conjugated to aminohexylCE) modification improves the pharmacokinetic properties of the resulting oligonucleotide drugs, allowing for enhanced cellular uptake and longer half-life in the body. Alternative Names: dA-PACE Phosphoramidite; 5'-Dimethoxytrityl-N-benzoyl-2'-deoxyAdenosine, 3'-O-(N,N-diisopropylamino)-phosphinyl-1,1-dimethyl-2-cyanoethyl acetate; Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-, 3'-[P-[2-(2-cyano-1,1-dimethylethoxy)-2-oxoethyl]-N,N-bis(1-methylethyl)phosphonamidite]; DNA A(Bz) PACE amidite. Grades: ≥95%. CAS No. 411234-24-7. Molecular formula: C51H58N7O8P. Mole weight: 928.02. | |
| DACA | DACA (XR 5000) is a potential and blood-brain barrier-penetrating topoisomerase I and II inhibitor. DACA can be used in the research of colorectal cancer, leukemia and lung cancer[1][2][3][4]. Uses: Scientific research. Category: Signaling pathways. CAS No. 89459-25-6. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-100777. | |
| Dacanal | Decanal is an aliphatic reagent used in the preparation of a new class of antibacterials resulting from erythromycin derivatives. Also used in the preparation of 2,4-disubstituted pyrrolidines from aldehydes. Group: Biochemicals. Grades: Highly Purified. CAS No. 112-31-2. Pack Sizes: 50g, 100g, 250g, 500g, 1kg. Molecular Formula: C??H??O, Molecular Weight: 156.27. US Biological Life Sciences. |  Worldwide |
| Dacarbazine | Dacarbazine. Group: Biochemicals. Grades: Highly Purified. CAS No. 4342-3-4. Pack Sizes: 500mg, 1g, 2g, 5g. US Biological Life Sciences. | Worldwide |
| Dacarbazine | Dacarbazine is an antineoplastic chemotherapy drug used in the treatment of various cancers.Dacarbazine is a member of the class of alkylating agents, which destroy cancer cells by adding an alkyl group (CnH2n+1) to its DNA. Uses: Anti-tumor. Alternative Names: DTIC-Dome. Grades: >98%. CAS No. 4342-3-4. Molecular formula: C6H10N6O. Mole weight: 182.18. | |
| Dacarbazine | 100mg Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C6H10N6O. CAS No. 4342-3-4. Prepack ID 26535422-100mg. Molecular Weight 182.18. See USA prepack pricing. |  |
| Dacarbazine | Dacarbazine is a nonspecific antineoplastic (antineoplastic) alkylating agent. Dacarbazine inhibits T and B lymphocyte responses with IC50 of 50 and 10 μg/mL, respectively. Dacarbazine can be used in the study of metastatic malignant melanoma[1][2][3][4][5]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Imidazole Carboxamide. CAS No. 4342-3-4. Pack Sizes: 10 mM * 1 mL in DMSO; 50 mg; 100 mg; 200 mg; 1 g. Product ID: HY-B0078. | |
| Dacarbazine-d6 | Labeled Dacarbazine. Dacarbazine is used as an antineoplastic for treatment of malignant melanoma and sarcomas. Group: Biochemicals. Alternative Names: 5-[3,3-Di-(methyl-d3)-1-triazenyl]imidazole-4-carboxamide; DTIC-d6; DIC-d6; NSC-45388-d6; Dacatic-d6; Deticene-d6. Grades: Highly Purified. CAS No. 1185241-28-4. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Dacarbazine-[d6] | Dacarbazine-[d6] is the isotope labelled analog of Dacarbazine. Dacarbazine is a chemotherapy medication used in the treatment of melanoma and Hodgkin's lymphoma. Alternative Names: Dacarbazine D6; 5-[3,3-Di-(methyl-d3)-1-triazenyl]imidazole-4-carboxamide; DTIC-d6; DIC-d6. Grades: 95% by HPLC; 98% atom D. CAS No. 1185241-28-4. Molecular formula: C6H4D6N6O. Mole weight: 188.22. | |
| Dacarbazine EP Impurity A | Dacarbazine EP Impurity A. Uses: For analytical and research use. CAS No. 4656-86-4. Molecular formula: C4H3N5O. Mole weight: 137.1. Catalog: APB4656864. |  |
| Dacarbazine EP Impurity A (Sodium Salt) | Dacarbazine EP Impurity A (Sodium Salt). Uses: For analytical and research use. Alternative Names: 2-Azahypoxanthine Sodium Salt; sodium 7H-imidazo[4,5-d][1,2,3]triazin-4-olate. CAS No. 1797817-35-6. Molecular formula: C4H4N5NaO. Mole weight: 161.1. Catalog: APB1797817356. | |
| Dacarbazine EP Impurity B | Dacarbazine EP Impurity B. Uses: For analytical and research use. Alternative Names: 5-amino-1H-imidazole-4-carboxamide. CAS No. 360-97-4. Molecular formula: C4H6N4O. Mole weight: 126.12. Catalog: APB360974. | |
| Dacarbazine EP Impurity B (Hydrochloride) | Dacarbazine EP Impurity B (Hydrochloride). Uses: For analytical and research use. Alternative Names: 360-97-4(free base); 5-amino-1H-imidazole-4-carboxamide hydrochloride. CAS No. 72-40-2. Molecular formula: C4H6N4O·HCl. Mole weight: 162.58. Catalog: APB72402. | |
| Dacarbazine EP Impurity C | Dacarbazine EP Impurity C. Uses: For analytical and research use. Alternative Names: 5-diazenyl-1H-imidazole-4-carboxamide. CAS No. 1314929-56-0. Molecular formula: C4H5N5O. Mole weight: 139.12. Catalog: APB1314929560. | |
| Dacarbazine EP Impurity D | Dacarbazine EP Impurity D. Uses: For analytical and research use. CAS No. 93803-04-4. Molecular formula: C2H7N. Mole weight: 45.09. Catalog: APB93803044. | |
| Dacarbazine Impurity 4 | Dacarbazine Impurity 4. Uses: For analytical and research use. Alternative Names: 4H-imidazo[4,5-d][1,2,3]triazin-4-one. CAS No. 63907-29-9. Molecular formula: C4HN5O. Mole weight: 135.08. Catalog: APB63907299. | |
| Dacarbazine Lactose Adduct Impurity | Dacarbazine Lactose Adduct Impurity. Uses: For analytical and research use. Alternative Names: 5-((((2R,3S,4R,5R,6R)-4,5,6-trihydroxy-3-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)methyl)amino)-1H-imidazole-4-carboxamide. Molecular formula: C16H26N4O11. Mole weight: 450.40. Catalog: APB05451. | |
| Dacarbazine Liposome | Dacarbazine (DTIC) is a triazene compound and the first-line treatment for melanoma. This product is a pre-formulated liposome encapsulating Dacarbazine. It is only for research purposes. Group: Drug-loaded liposome. |  |
| Dacarbazine Related Compound A | Dacarbazine Related Compound A. Uses: For analytical and research use. CAS No. 72-40-2. Mole weight: 162.58. Catalog: AP72402. | |
| Dacarbazine Related Compound B | Dacarbazine Related Compound B. Uses: For analytical and research use. CAS No. 4656-86-4 (anhydrous). Mole weight: 155.11. Catalog: ALP4656864. | |
| Dacetuzumab | Dacetuzumab (SGN-40) is a humanized IgG1, anti-CD40 monoclonal antibody with anti-lymphoma activity. Dacetuzumab kills tumor cells via immune effector functions (antibody-dependent cellular cytotoxicity and phagocytosis [ADCC/ADCP]). Dacetuzumab ((SGN-40) can be used for multiple myeloma research[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 880486-59-9. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99015. | |
| Dacinostat | Dacinostat is a potent HDAC inhibitor, with an IC50 of 32 nM; Dacinostat also inhibits HDAC1 with an IC50 of 9 nM, and used in cancer research. Uses: Scientific research. Category: Signaling pathways. Alternative Names: NVP-LAQ824; LAQ824. CAS No. 404951-53-7. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 500 mg; 1 g. Product ID: HY-13606. | |
| Daclatasvir | Daclatasvir, inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Alternative Names: Daclatasvir; BMS-790052; BMS 790052; BMS790052; EBP-883; EBP 883; EBP883; trade name Daklinza. Grades: 0.98. CAS No. 1009119-64-5. Molecular formula: C40H50N8O6. Mole weight: 738.89. | |
| Daclatasvir | Daclatasvir (BMS-790052) is a potent and orally active HCV NS5A protein inhibitor with EC50s range of 9-146 pM for multiple HCV replicon genotypes. Daclatasvir is also a organic anion transporting polypeptide 1B (OATP1B) and OATP1B3 inhibitor with IC50s of 1.5 μM and 3.27 μM, respectively[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BMS-790052; EBP 883. CAS No. 1009119-64-5. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 200 mg. Product ID: HY-10466. | |
| Daclatasvir | Daclatasvir. Group: Biochemicals. Grades: Highly Purified. CAS No. 1009119-64-5. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. US Biological Life Sciences. | Worldwide |
| Daclatasvir Diethyl Ester-d10 | Daclatasvir Diethyl Ester-d10 is the isotope labelled analog of Daclatasvir Diethyl Ester (D101525); an impurity of Daclatasvir (D101500) which is a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg, 5mg. Molecular Formula: C42H44D10N8O6, Molecular Weight: 776.99. US Biological Life Sciences. | Worldwide |
| Daclatasvir dihydrochloride | Daclatasvir is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture. Alternative Names: Methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate dihydrochloride; Daclatasvir; BMS790052; BMS 790052; BMS-790052; EBP883; EBP 883; EBP-883; Daklinza. Grades: >98%. CAS No. 1009119-65-6. Molecular formula: C40H50N8O6·2HCl. Mole weight: 811.8. | |
| Daclatasvir Impurity 1 | Daclatasvir Impurity 1. Uses: For analytical and research use. CAS No. 2698401-11-3. Molecular formula: C40H51ClN8O6. Mole weight: 775.35. Catalog: APB2698401113. | |
| Daclatasvir Impurity 10 | Daclatasvir Impurity 10. Uses: For analytical and research use. CAS No. 1009119-83-8. Molecular formula: C26H29ClN6. Mole weight: 461.01. Catalog: APB1009119838. | |
| Daclatasvir Impurity 11 | Daclatasvir Impurity 11. Uses: For analytical and research use. CAS No. 1007882-23-6. Molecular formula: C36H44N6O4. Mole weight: 624.79. Catalog: APB1007882236. | |
| Daclatasvir Impurity 1 (RSSS-Isomer) | Daclatasvir Impurity 1 (RSSS-Isomer). Uses: For analytical and research use. Alternative Names: dimethyl ((2S,2'R)-((2S,2'S)-2,2'-(5,5'-([1,1'-biphenyl]-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl))dicarbamate. CAS No. 1417333-83-5. Molecular formula: C40H50N8O6. Mole weight: 738.88. Catalog: APB1417333835. | |
| Daclatasvir Impurity 1 (SRSS-Isomer) | Daclatasvir Impurity 1 (SRSS-Isomer). Uses: For analytical and research use. Alternative Names: Daclatasvir Impurity 1 (SRSS-Isomer). CAS No. 1009117-28-5. Molecular formula: C40H50N8O6. Mole weight: 738.88. Catalog: APB1009117285. | |
| Daclatasvir Impurity 3 | Daclatasvir Impurity 3. Uses: For analytical and research use. CAS No. 2226822-77-9. Molecular formula: C40H51ClN8O6. Mole weight: 775.35. Catalog: APB2226822779. | |
| Daclatasvir Impurity 4 | Daclatasvir Impurity 4. Uses: For analytical and research use. CAS No. 1009117-26-3. Molecular formula: C40H50N8O6. Mole weight: 738.89. Catalog: APB1009117263. | |
| Daclatasvir Impurity 5 | Daclatasvir Impurity 5. Uses: For analytical and research use. CAS No. 1009107-27-0. Molecular formula: C40H50N8O6. Mole weight: 738.89. Catalog: APB1009107270. | |
| Daclatasvir Impurity 6 | Daclatasvir Impurity 6. Uses: For analytical and research use. CAS No. 2077207-88-4. Molecular formula: C41H52N8O6. Mole weight: 752.92. Catalog: APB2077207884. | |
| Daclatasvir Impurity 7 | Daclatasvir Impurity 7. Uses: For analytical and research use. Molecular formula: C40H49N7O7. Mole weight: 739.87. Catalog: APB12391. | |
| Daclatasvir Impurity 8 | Daclatasvir Impurity 8. Uses: For analytical and research use. CAS No. 2226541-13-3. Molecular formula: C35H41N7O4. Mole weight: 623.76. Catalog: APB2226541133. | |
| Daclatasvir Impurity 9 | Daclatasvir Impurity 9. Uses: For analytical and research use. CAS No. 1007884-60-7. Molecular formula: C33H39N7O3. Mole weight: 581.72. Catalog: APB1007884607. | |
| Daclizumab | Daclizumab (Ro 24-7375) is a humanized, monoclonal antibody that blocks CD25 (α-subunit of the high-affinity interleukin-2 receptor (IL-2R-HA)). Daclizumab inhibits effector T cell activation, regulatory T cell (Treg) expansion and survival, and activation-induced T-cell apoptosis. Daclizumab increases IL-2 bioavailability to bind to the intermediate-affinity IL-2R (IL-2R-IA), driving the expansion of anti-inflammatory CD56bright natural killer (NK) cells. Daclizumab can be used for multiple sclerosis and cancer research[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Ro 24-7375. CAS No. 152923-56-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-108738. | |
| DACM | DACM (N-(7-Dimethylamino-4-methyl-3-coumarinyl)maleimide) is a thiol-directed fluorescent dye (Ex=396 nm, Em=468 nm)[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: N-(7-Dimethylamino-4-methyl-3-coumarinyl)maleimide. CAS No. 55145-14-7. Pack Sizes: 1 mg. Product ID: HY-121030. | |
| Dacomitinib | Dacomitinib (PF-00299804) is a specific and irreversible inhibitor of the ERBB family of kinases with IC50s of 6 nM, 45.7 nM and 73.7 nM for EGFR, ERBB2, and ERBB4, respectively[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: PF-00299804; PF-299804. CAS No. 1110813-31-4. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg. Product ID: HY-13272. | |
| Dacomitinib | Dacomitinib (PF299)(PF299804; PF-00299804) is a highly selective, orally bioavailable small-molecule inhibitor of the HER family of tyrosine kinases with IC50 of 6, 45.7 and 73.7 nM for EGFR, ERBB2, and ERBB4, respectively. Category: Active pharmaceutical ingredients. Synonyms: PF-299804, PF-00299804, PF299. Grades: DMF. CAS No. 1110813-31-4. Product ID: API1110813314. Molecular formula: C24H25ClFN5O2. Mole weight: 469.94. Standard: Facility GMP. |  |
| Dacomitinib | Dacomitinib, aslo known as PF-299 and PF-00299804; or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Dacomitinib specifically and irreversibly binds to and inhibits human EGFR subtypes, resulting in inhibition of proliferation and induction of apoptosis in EGFR-expressing tumor cells. EGFRs play major roles in tumor cell proliferation and tumor vascularization, and are often overexpressed or mutated in various tumor cell types. Alternative Names: dacomitinib; PF-00299804; PF00299804; PF 00299804; PF299804; PF-299804; PF 299804; PF-299; PF 299; PF299. CAS No. 1110813-31-4. Molecular formula: C24H25ClFN5O2. Mole weight: 469.945. | |
| Dacomitinib hydrate | Dacomitinib hydrate (PF 299804) is a highly selective and second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor family of tyrosine kinases. Category: Active pharmaceutical ingredients. Synonyms: PF 299804. CAS No. 1042385-75-0. Product ID: API1042385750. Molecular formula: C24H27ClFN5O3. Mole weight: 487.96. | |
| Dacomitinib Impurity 1 | Dacomitinib Impurity 1. Uses: For analytical and research use. Molecular formula: C8H3FN4O5. Mole weight: 254.13. Catalog: APB12399. | |
| Dacomitinib Impurity 10 | Dacomitinib Impurity 10. Uses: For analytical and research use. Alternative Names: (E)-N-(4-((3,4-difluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular formula: C24H25F2N5O2. Mole weight: 453.48. Catalog: APB05285. | |
| Dacomitinib Impurity 10 | Dacomitinib Impurity 10. Uses: For analytical and research use. CAS No. 2106-05-0. Molecular formula: C6H5ClFN. Mole weight: 145.56. Catalog: APB2106050. | |
| Dacomitinib Impurity 11 | Dacomitinib Impurity 11. Uses: For analytical and research use. CAS No. 13991-36-1. Molecular formula: C4H5BrO2. Mole weight: 164.99. Catalog: APB13991361. | |
| Dacomitinib Impurity 11 | Dacomitinib Impurity 11. Uses: For analytical and research use. Alternative Names: (E)-N-(4-((4-chloro-3-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular formula: C24H25ClFN5O2. Mole weight: 469.94. Catalog: APB05284. | |
| Dacomitinib Impurity 12 | Dacomitinib Impurity 12. Uses: For analytical and research use. Alternative Names: (E)-N-(4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular formula: C24H25ClFN5O2. Mole weight: 469.94. Catalog: APB05283. | |
| Dacomitinib Impurity 13 | Dacomitinib Impurity 13. Uses: For analytical and research use. Alternative Names: (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-fluoroquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular formula: C23H22ClF2N5O. Mole weight: 457.9. Catalog: APB05281. | |
| Dacomitinib Impurity 14 | Dacomitinib Impurity 14. Uses: For analytical and research use. Molecular formula: C26H32ClFN6O2. Mole weight: 515.03. Catalog: APB12400. | |
| Dacomitinib Impurity 15 | Dacomitinib Impurity 15. Uses: For analytical and research use. Alternative Names: (E)-N-(5-cyano-4-((E)-((dimethylamino)methylene)amino)-2-methoxyphenyl)-4-(piperidin-1-yl)but-2-enamide. Molecular formula: C20H27N5O2. Mole weight: 369.46. Catalog: APB05282. | |
| Dacomitinib Impurity 16 | Dacomitinib Impurity 16. Uses: For analytical and research use. Alternative Names: (E)-N-(4-((4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular formula: C24H26FN5O2. Mole weight: 435.49. Catalog: APB05280. | |
| Dacomitinib Impurity 17 | Dacomitinib Impurity 17. Uses: For analytical and research use. Alternative Names: (E)-N-(4-((3-chlorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular formula: C24H26ClN5O2. Mole weight: 451.95. Catalog: APB05279. | |
| Dacomitinib Impurity 2 | Dacomitinib Impurity 2. Uses: For analytical and research use. Alternative Names: 2-chloro-1-fluoro-4-nitrobenzene. CAS No. 350-30-1. Molecular formula: C6H3ClFNO2. Mole weight: 175.54. Catalog: APB350301. | |
| Dacomitinib Impurity 2 | Dacomitinib Impurity 2. Uses: For analytical and research use. Molecular formula: C8H4N4O6. Mole weight: 252.14. Catalog: APB12398. | |
| Dacomitinib Impurity 3 | Dacomitinib Impurity 3. Uses: For analytical and research use. CAS No. 2250242-14-7. Molecular formula: C8H4N4O6. Mole weight: 252.14. Catalog: APB2250242147. | |
| Dacomitinib Impurity 4 | Dacomitinib Impurity 4. Uses: For analytical and research use. Alternative Names: 1-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-5-(piperidin-1-yl)pyrrolidin-2-one. Molecular formula: C24H25ClFN5O2. Mole weight: 469.94. Catalog: APB05290. | |
| Dacomitinib Impurity 5 | Dacomitinib Impurity 5. Uses: For analytical and research use. Alternative Names: 1-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-5-hydroxypyrrolidin-2-one. CAS No. 2190490-31-2. Molecular formula: C19H16ClFN4O3. Mole weight: 402.81. Catalog: APB2190490312. | |
| Dacomitinib Impurity 5 | Dacomitinib Impurity 5. Uses: For analytical and research use. CAS No. 53449-14-2. Molecular formula: C8H4ClN3O3. Mole weight: 225.59. Catalog: APB53449142. | |
| Dacomitinib Impurity 6 | Dacomitinib Impurity 6. Uses: For analytical and research use. Alternative Names: 5-((3-chloro-4-fluorophenyl)amino)-1-(4-((3-chlorophenyl)amino)-7-methoxyquinazolin-6-yl)pyrrolidin-2-one. Molecular formula: C25H20Cl2FN5O2. Mole weight: 512.36. Catalog: APB05288. | |
| Dacomitinib Impurity 7 | Dacomitinib Impurity 7. Uses: For analytical and research use. CAS No. 2168856-93-5. Molecular formula: C7H5FN2O4. Mole weight: 200.13. Catalog: APB2168856935. | |
| Dacomitinib Impurity 7 | Dacomitinib Impurity 7. Uses: For analytical and research use. Alternative Names: (E)-N-(3-(3-chloro-4-fluorophenyl)-4-imino-7-methoxy-3,4-dihydroquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular formula: C24H25ClFN5O2. Mole weight: 469.94. Catalog: APB05289. | |
| Dacomitinib Impurity 8 | Dacomitinib Impurity 8. Uses: For analytical and research use. Alternative Names: (E)-N-(4-(N-(3-chloro-4-fluorophenyl)acetamido)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular formula: C26H27ClFN5O3. Mole weight: 511.98. Catalog: APB05286. | |
| Dacomitinib Impurity 9 | Dacomitinib Impurity 9. Uses: For analytical and research use. Alternative Names: (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)but-2-enamide. Molecular formula: C19H16ClFN4O2. Mole weight: 386.81. Catalog: APB05287. | |
| Dacomitinib Impurity 9 | Dacomitinib Impurity 9. Uses: For analytical and research use. CAS No. 119023-25-5. Molecular formula: C7H7FN2O. Mole weight: 154.14. Catalog: APB119023255. | |
Our database is helping our users find suppliers everyday.
